ArticleScientific reports2026
Modulating the sialic acid content of endothelial cells affects their adhesion and barrier permeability.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The crossing of the endothelial cell layer and the glycocalyx that shields it can be considered the final barrier for substances trying to pass from the blood into the surrounding tissue. Due to their terminal position on glycan structures, sialic acids constitute the initial point of contact encountered by invading substances or bacteria. In this study, we investigated the influence of varying sialic acid levels on endothelial cell adhesion and barrier permeability. Furthermore, the successful desialylation as well as the potential for resialylation of two natively sialylated proteins - podocalyxin and integrin beta-1 - were investigated in detail. Desialylation of the cells was achieved either by sialidase-treatment or by knocking out the key enzyme of the sialic acid biosynthesis - the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE). We could confirm a sialic acid deficiency after both approaches, which was more pronounced in the GNE-KO cells than in the sialidase-treated cells. Furthermore, a reduced barrier permeability and a negative effect on adhesion were observed. Partial resialylation of GNE-KO cells was achieved either by supplementation with N-acetylmannosamine (ManNAc) or with N-acetylneuraminic acid (Neu5Ac); however, the effects on adhesion and permeability were not fully compensated thereby.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.